In a significant move within the Indian healthcare sector, Dr. Reddy’s Laboratories Ltd. and Bayer have announced a collaborative partnership aimed at the marketing and distribution of a second brand of the heart failure drug Vericiguat under the brand name Gantra in India. This partnership grants Dr. Reddy’s non-exclusive rights to market Vericiguat, marking a […]
Bayer AG and its subsidiary Asklepios BioPharmaceutical, Inc. (AskBio), have achieved a significant milestone in the fight against congestive heart failure (CHF) with the randomization of the first patient in the Phase II GenePHIT trial for AB-1002 (NAN-101). This trial represents a critical step forward in the development of new treatments for CHF, a condition […]
In a significant development for the Indian healthcare sector, Sun Pharmaceutical Industries Limited and Bayer have announced a collaborative agreement to market and distribute a second brand of Finerenone in India. This move is set to revolutionize the treatment landscape for chronic kidney disease (CKD) associated with type 2 diabetes mellitus (T2DM). Finerenone: A Game-Changer […]
Bayer has received US Food and Drug Administration (FDA) approval for Ultravist (iopromide) injection, its iodine-based contrast agent, to be used for contrast-enhanced mammography (CEM). This marks Ultravist as the sole contrast agent approved for this purpose. The product will be employed to enhance visualization of known or suspected breast lesions in adult patients, complementing […]
OpenText said that German healthcare major Bayer has selected OpenText Business Network Cloud Enterprise as a solution for certain B2B integration activities within the consumer health and pharmaceuticals divisions to boost agility and enhance operational efficiencies. According to OpenText, the collaboration was started with a proof-of-concept, which will be followed by roll-out activities. Bayer through […]
Bayer has acquired Blackford Analysis, a Scottish imaging artificial intelligence (AI) platform, to strengthen its footprint in the digital medical imaging market. The acquisition forms part of the German life-science company’s strategy to improve patient care through innovation in radiology, including the development and adoption of AI within the clinical workflow. The financial terms of […]
Bayer has agreed to sell Nebido (testosterone undecanoate), its men’s health product, to German pharma company Grünenthal for a price of up to €500 million. Nebido, which is used for treating male hypogonadism (testosterone deficiency), is available in more than 80 countries since 2004. Last year, the men’s health product contributed €117 million in sales […]
Andes Ag, Inc., an agriculture and biotechnology innovator based in California, has raised $15 million in a Series A round co-led by Bayer’s impact investment arm — Leaps by Bayer and Cavallo Ventures. Other new investors taking part in the funding round include Builders VC, Accelr8, Germin8, and Wilson Sonsini. The Series A round also […]
Chronos-3 trial results : Bayer said that the investigational combination of Aliqopa (copanlisib) and rituximab considerably increased progression-free survival (PFS) in patients having relapsed indolent non-Hodgkin’s Lymphoma (iNHL) in the phase 3 CHRONOS-3 clinical trial. The late-stage trial, which featured 458 patients, compared the Aliqopa, rituximab combo in comparison to the combination of rituximab and […]
German pharma giant Bayer has agreed to acquire US clinical-stage gene therapy company Asklepios BioPharmaceutical in a deal worth up to $4 billion. The portfolio of Asklepios BioPharmaceutical features investigational pre-clinical and clinical stage candidates, which are being developed for the treatment of neuromuscular, cardiovascular, central nervous system, and metabolic diseases. Asklepios BioPharmaceutical was established […]